In a region where promising medical technologies too often stall between invention and bedside, IHH Healthcare is opening its hospital doors to entrepreneurs as a deliberate act of institutional faith. On July 27, 2026, the multinational healthcare operator announced the North Asia Edition of its IHH Catalyst accelerator, anchoring the programme through Gleneagles Hospital Hong Kong and Parkway Shanghai to help early-stage startups compress years of adoption friction into a focused three-month engagement. The move reflects a broader conviction that the future of healthcare will not be written